Recurrence means that cancer has come back after initial treatment and a period during which it could not be detected. Even after successful treatment, some cancer cells may survive in the body and ...

Treatment with 300 mg IV eptinezumab in adults with chronic migraine resulted in rapid and sustained reduction in the number of headache days that was largely sustained up to 84 weeks, according to a ...

Weight loss medications containing liraglutide could provide significant relief for millions of migraine sufferers, according ...

Erenumab is not associated with significant reductions in weekly attacks in patients with chronic cluster headache vs placebo ...

More than 37 million people here in the United States suffer from migraines. If you’re one of them, you know they can be caused by different factors like the weather. But how exactly does the ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...

Patients with migraine discontinued treatment less often with atogepant and experienced a greater reduction in mean monthly ...

Atogepant 60 mg once daily leads to meaningful weight loss in patients with overweight or obesity receiving preventive ...

When the brain gets shaken, it can result in a concussion -- an injury that often goes unnoticed or underestimated.

More than 37 million people in the United States suffer from migraines. If you’re one of them, you know they can be triggered ...

A 75% plus increase in good days/month with eptinezumab is associated with improved migraine symptoms, brain fog, and overall well-being in chronic migraine.

About 50% of patients have headache after a hemorrhagic stroke, and more than a third report severe pain — yet headache care ...